New Blood Test Boosts Alzheimer's Accuracy to 91%

Diagnostic accuracy for Alzheimer's disease is crucial, especially when symptoms overlap with normal aging. Conventional clinical assessments offer a diagnostic accuracy of only 61%, whereas advanced blood-based testing has now elevated this precision to 91%. These blood biomarkers provide a clearer indication of whether memory loss is linked to Alzheimer's.

For families in India, this development means a reliable diagnosis can now begin with a simple blood draw at a local clinic, making the process accessible and fast. This advancement potentially reduces reliance on more complex methods like advanced imaging or spinal fluid testing.

However, the test is currently recommended only for individuals already showing signs of memory loss. Broad screening for everyone is not advised, as common conditions such as chronic kidney disease can interfere with and skew the results, leading to potential misinterpretations.

Neurologists also suggest that individuals experiencing early cognitive changes, even those not solely related to memory loss, may consider this test after consulting a doctor. This allows for a more comprehensive approach to early detection and management.